Akoya Biosciences, Inc. (NASDAQ:AKYA) Q3 2021 Earnings Conference Call November 8, 2021 5:00 PM ET
Company Participants
Priyam Shah - IR
Brian McKelligon - CEO
Joe Driscoll - CFO
Conference Call Participants
Kyle Mikson - Canaccord
Operator
Ladies and gentlemen, thank you for standing by and welcome to the Q3 2021 Akoya Biosciences' Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions]
I would now like to turn the conference over to your speaker for today Priyam Shah. You may begin
Priyam Shah
Good afternoon everyone. Thank you for joining us today. I'm Priyam Shah, Head of Investor Relations at Akoya Biosciences. On the call today we have Brian McKelligon, Chief Executive Officer; and Joe Driscoll, Chief Financial Officer. Earlier today, Akoya released financial results for the third quarter ended September 30th, 2021. A copy of the press release is available on the company's website.
Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of the federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.
Any statements contained in this call that relate to expectations or predictions of future events, results, or performance are forward-looking statements. Actual results may differ materially from those expressed or implied in the forward-looking statements due to a variety of factors.
For a list and description of the risks and uncertainties associated with Akoya's business, please refer to the Risk Factors section of our Form S-1 filed with the Securities and Exchange Commission on April 15th, 2021. We urge you to consider these factors and you
- Read more current AKYA analysis and news
- View all earnings call transcripts